VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

ICML 2019 | Resisting CAR-T resistance in lymphoma: the strategies

Sattva Neelapu, MD, University of Texas MD Anderson Cancer Center, Houston, TX, discusses the strategies to overcome or avoid resistance to anti-CD19 CAR T-cell therapy in lymphoma. This interview took place at the 15th International Conference on Malignant Lymphoma (ICML), in Lugano, Switzerland.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter